前哨淋巴结示踪 vs 系统性淋巴结清扫治疗子宫内膜癌:手术并发症与淋巴相关并发症
该回顾性队列研究纳入2013年4月至2018年3月在一家三级转诊医院手术治疗的250例子宫内膜癌患者,比较单纯子宫切除、子宫切除加前哨淋巴结活检、子宫切除加淋巴结清扫(伴或不伴腹主动脉旁清扫)及联合组的并发症;前哨淋巴结活检未增加并发症,淋巴结清扫与30天并发症、术中并发症及下肢淋巴水肿风险升高相关。
要点
- 与单纯子宫切除相比,子宫切除加前哨淋巴结活检未增加术中并发症(0 vs 1;p=1.0)和30天并发症(8 vs 7;p=.782),但手术时间约延长20分钟(p=.016)。
- 淋巴结清扫与30天并发症风险升高相关(HR 3.11;95%CI 1.62-5.98)。
- 淋巴结清扫与术中并发症风险升高相关(HR 14.25;95%CI 1.85-19.63)。
核心结论
- 前哨淋巴结示踪不增加子宫内膜癌患者手术治疗的并发症,且与全面淋巴结清扫相比并发症风险更低。
- 作者认为研究结果支持在子宫内膜癌患者中使用前哨淋巴结算法。
研究设计与样本
- 回顾性队列研究,在一家三级转诊医院进行。
- 纳入2013年4月至2018年3月因子宫内膜癌接受手术治疗的全部患者,共250例。
- 按淋巴结处理方式分为4组:I组单纯子宫切除;II组子宫切除加前哨淋巴结活检;III组子宫切除加盆腔淋巴结清扫(伴或不伴腹主动脉旁清扫);IV组子宫切除加淋巴结清扫加前哨淋巴结活检。
- 采用纪念斯隆-凯特琳癌症中心手术次要事件分级系统评估术中并发症和30天并发症。
主要发现
- 与单纯子宫切除组相比,子宫切除加前哨淋巴结活检组术中并发症为0 vs 1(p=1.0),30天并发症为8 vs 7(p=.782),差异无统计学意义。
- 子宫切除加前哨淋巴结活检组手术时间较单纯子宫切除组约延长20分钟(p=.016)。
- 淋巴结清扫与30天并发症风险升高相关(HR 3.11;95%CI 1.62-5.98)。
- 淋巴结清扫与术中并发症风险升高相关(HR 14.25;95%CI 1.85-19.63)。
- 淋巴结清扫与下肢淋巴水肿风险升高相关(HR 8.14;95%CI 1.01-65.27)。
关键数值与推荐
- 与单纯子宫切除相比,子宫切除加前哨淋巴结活检的术中并发症为0 vs 1(p=1.0),30天并发症为8 vs 7(p=.782)。
- 子宫切除加前哨淋巴结活检较单纯子宫切除手术时间约延长20分钟(p=.016)。
- 淋巴结清扫的30天并发症HR 3.11(95%CI 1.62-5.98)。
- 淋巴结清扫的术中并发症HR 14.25(95%CI 1.85-19.63)。
- 淋巴结清扫的下肢淋巴水肿HR 8.14(95%CI 1.01-65.27)。
临床怎么用
- 作者认为前哨淋巴结示踪不增加子宫内膜癌手术并发症,且较全面淋巴结清扫并发症风险更低。
- 作者认为研究结果支持在子宫内膜癌患者中使用前哨淋巴结算法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: Sentinel lymph node (SLN) mapping has been proven to accurately stage endometrial cancer (EC). However, there is a lack of studies comparing the incidence of complications between different lymph node approaches in EC. The objective of the study was to define the complication rates of SLN biopsy in EC patients. DESIGN: A retrospective cohort study SETTING: A tertiary referral hospital PATIENTS: All patients who were surgically treated for EC form April 2013 to March 2018 INTERVENTIONS: Authors evaluated intraoperative complications and 30-day complications using the Memorial Sloan Lettering Cancer Center's Surgical Secondary Events Grading System, separating the patients into 4 groups: group I, hysterectomy (HT); group II, hysterectomy plus sentinel lymph node biopsy (HT+SLN); group III, hysterectomy plus pelvic lymphadenectomy, with or without para-aortic dissection (HT+LND); and group IV, hysterectomy plus lymphadenectomy and sentinel lymph node biopsy (HT+SLN+LND). MEASUREMENTS AND MAIN RESULTS: Authors identified a total of 250 cases. As compared with the HT group, the HT+SLN group did not show any increased risk of complications in terms of intraoperative complications (0 vs 1; p = 1.0) and 30-day complications (8 vs 7; p = .782), but surgical time was approximately 20 minutes longer (p = .016). Performing LND was associated with a greater risk of 30-day complications (hazard ratio [HR]: 3.11; 95% confidence interval [CI]: 1.62-5.98), intraoperative complications (HR: 14.25; 95% CI: 1.85-19.63), and lower-limb lymphedema (HR: 8.14; 95% CI: 1.01-65.27). CONCLUSION: SLN mapping does not increase morbidity in the surgical treatment of EC patients, and compared with comprehensive lymphadenectomy, it has a lower risk of complications. Our findings support the use of the SLN algorithm in EC patients.
引用
- Accorsi GS, Paiva LL, Schmidt R, et al. Sentinel Lymph Node Mapping vs Systematic Lymphadenectomy for Endometrial Cancer: Surgical Morbidity and Lymphatic Complications. J Minim Invasive Gynecol. 2019. PMID: 31421249. doi:10.1016/j.jmig.2019.07.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。